Correlation Between Ningbo MedicalSystem and Hengerda New

Can any of the company-specific risk be diversified away by investing in both Ningbo MedicalSystem and Hengerda New at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ningbo MedicalSystem and Hengerda New into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ningbo MedicalSystem Biotechnology and Hengerda New Materials, you can compare the effects of market volatilities on Ningbo MedicalSystem and Hengerda New and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ningbo MedicalSystem with a short position of Hengerda New. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ningbo MedicalSystem and Hengerda New.

Diversification Opportunities for Ningbo MedicalSystem and Hengerda New

0.97

Correlation Coefficient

Ningbo MedicalSystem  Hengerda New

Almost no diversification

The 3 months correlation between Ningbo and Hengerda is 0.97. Overlapping area represents the amount of risk that can be diversified away by holding Ningbo MedicalSystem Biotechno and Hengerda New Materials in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hengerda New Materials and Ningbo MedicalSystem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ningbo MedicalSystem Biotechnology are associated (or correlated) with Hengerda New. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hengerda New Materials has no effect on the direction of Ningbo MedicalSystem i.e., Ningbo MedicalSystem and Hengerda New go up and down completely randomly.

Pair Corralation between Ningbo MedicalSystem and Hengerda New

Assuming the 90 days trading horizon Ningbo MedicalSystem is expected to generate 1.19 times less return on investment than Hengerda New. But when comparing it to its historical volatility, Ningbo MedicalSystem Biotechnology is 1.1 times less risky than Hengerda New. It trades about 0.13 of its potential returns per unit of risk. Hengerda New Materials is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  2,192  in Hengerda New Materials on September 21, 2024 and sell it today you would earn a total of  663.00  from holding Hengerda New Materials or generate 30.25% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Strong
Accuracy	100.0%
Values	Daily Returns

Ningbo MedicalSystem Biotechno  vs.  Hengerda New Materials

Ningbo MedicalSystem

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Ningbo MedicalSystem Biotechnology are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ningbo MedicalSystem sustained solid returns over the last few months and may actually be approaching a breakup point.

Hengerda New Materials

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Hengerda New Materials are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Hengerda New sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ningbo MedicalSystem and Hengerda New

The main advantage of trading using opposite Ningbo MedicalSystem and Hengerda New positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ningbo MedicalSystem position performs unexpectedly, Hengerda New can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hengerda New will offset losses from the drop in Hengerda New's long position.

The idea behind Ningbo MedicalSystem Biotechnology and Hengerda New Materials pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.